Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Bravo

Showing results (131-140 of 440) with videos related to

Pageof 44
Sort By:
The American Journal of Medicine|May 1, 1972
Physiologic characteristics of hypertensionH P Dustan, R C Tarazi, E L Bravo
Circulation|September 1, 1973
Spironolactone as a nonspecific treatment for primary aldosteronismE L Bravo, H P Dustan, R C Tarazi
The Journal of Clinical Endocrinology and Metabolism|March 1, 1975
Action of (1-des(aspartic acid), 8-isoleucine) angiotensin II upon the pressor and steroidogenic activity of angiotensin IIE L Bravo, M C Khosla, F M Bumpus
Atencion Primaria|September 1, 1992
[Acute hepatitis: an adverse reaction to fenofibrate treatment]M L Bravo, R Azagra, A Aguyé, et al.
The American Journal of Physiology|January 1, 1975
Vascular and adrenocortical responses to a specific antagonist of angiotensin IIE L Bravo, M C Khosla, F M Bumpus
The Journal of Clinical Endocrinology and Metabolism|September 1, 1975
Selective hypoaldosteronism despite prolonged pre- and postoperative hyperreninemia in primary aldosteronismE L Bravo, H P Dustan, R C Tarazi
Annals of Internal Medicine|August 1, 1976
Letter: Primary aldosteronism: remission and development of adrenal insufficiency after adrenal venographyH C Taylor, C R Sachs, E L Bravo
Circulation Research|June 1, 1976
The role of angiotensins in aldosterone productionE L Bravo, M C Khosla, F M Bumpus
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|October 1, 1983
Cardiac and haemodynamic effects of enalaprilF M Fouad, R C Tarazi, E L Bravo
Revista Medica De Chile|January 6, 2005
[The evaluation of decision making capacity in health care and its relationship to informed consent]Gladys E Bórquez, Gina B Raineri, Mireya L Bravo
Pageof 44

Showing results (131-140 of 440) with videos related to

Sort By:
Pageof 44
The American Journal of Medicine|May 1, 1972
Physiologic characteristics of hypertensionH P Dustan, R C Tarazi, E L Bravo
Circulation|September 1, 1973
Spironolactone as a nonspecific treatment for primary aldosteronismE L Bravo, H P Dustan, R C Tarazi
The Journal of Clinical Endocrinology and Metabolism|March 1, 1975
Action of (1-des(aspartic acid), 8-isoleucine) angiotensin II upon the pressor and steroidogenic activity of angiotensin IIE L Bravo, M C Khosla, F M Bumpus
Atencion Primaria|September 1, 1992
[Acute hepatitis: an adverse reaction to fenofibrate treatment]M L Bravo, R Azagra, A Aguyé, et al.
The American Journal of Physiology|January 1, 1975
Vascular and adrenocortical responses to a specific antagonist of angiotensin IIE L Bravo, M C Khosla, F M Bumpus
The Journal of Clinical Endocrinology and Metabolism|September 1, 1975
Selective hypoaldosteronism despite prolonged pre- and postoperative hyperreninemia in primary aldosteronismE L Bravo, H P Dustan, R C Tarazi
Annals of Internal Medicine|August 1, 1976
Letter: Primary aldosteronism: remission and development of adrenal insufficiency after adrenal venographyH C Taylor, C R Sachs, E L Bravo
Circulation Research|June 1, 1976
The role of angiotensins in aldosterone productionE L Bravo, M C Khosla, F M Bumpus
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|October 1, 1983
Cardiac and haemodynamic effects of enalaprilF M Fouad, R C Tarazi, E L Bravo
Revista Medica De Chile|January 6, 2005
[The evaluation of decision making capacity in health care and its relationship to informed consent]Gladys E Bórquez, Gina B Raineri, Mireya L Bravo
Pageof 44